Feb 06, 2026
1:25
For every 25 shares held, investors received 1. The price per share adjusted from $0.12 to $0.00.
The split itself did not change the total investment value.
Adial Pharmaceuticals, Inc. (ADIL) trades on the NASDAQ Capital Market in the Biotechnology industry.
Adial Pharmaceuticals, Inc. company overviewThe latest split shown was on February 6, 2026. It was a 1-for-25 reverse split, so shareholders received 1 share for every 25 they held.
This history records 2 reverse splits between August 7, 2023 and February 6, 2026.